Maintenance Guide · Updated March 2026

GLP-1 Maintenance Guide: What Happens When You Stop (2026)

Two-thirds of weight lost on semaglutide comes back within a year of stopping. The SURMOUNT-5 trial for tirzepatide tells a slightly better story, but the pattern holds: stopping GLP-1 medication without a plan leads to significant regain. This guide covers the full picture of GLP-1 maintenance, from the clinical data on what happens when you stop, to maintenance dosing strategies, to building the habits that give you a real shot at keeping the weight off.

I am seven months into Mounjaro, down to 181.6 lbs and about 22% body fat (tracked with DEXA scans). I have not stopped yet. But the question of when and how to stop, or whether to move to a lower maintenance dose, is something I think about constantly. The data on weight regain after GLP-1 cessation is sobering. Pretending I will be the exception without a strategy would be reckless.

This is the broader context for anyone on a GLP-1 who is thinking about their long-term plan. If you want the specific tactical protocol for tapering and building post-medication habits, read our GLP-1 exit strategy guide. This guide covers the why and when. That guide covers the how.

The Weight Regain Reality: What the Clinical Trials Show

The two most important datasets on GLP-1 discontinuation come from the STEP 1 extension trial (semaglutide) and SURMOUNT-4 and SURMOUNT-5 (tirzepatide). Both paint a clear picture.

STEP 1 Extension Trial (semaglutide 2.4mg): Participants lost an average of 17.3% of body weight on semaglutide. After stopping, they were followed for one year. Within 52 weeks off the drug, they regained approximately two-thirds of their lost weight. Cardiometabolic improvements in blood pressure, cholesterol, and blood sugar reversed in parallel with the weight gain.

SURMOUNT-4 (tirzepatide): Patients on tirzepatide who switched to placebo regained about 50% of their lost weight over 52 weeks. Those who stayed on the drug continued to lose or maintain. The tirzepatide data was modestly better than semaglutide, but the direction was identical.

SURMOUNT-5 Maintenance Data: This trial specifically examined long-term maintenance on tirzepatide. Patients who continued on tirzepatide at their therapeutic dose maintained their weight loss over 176 weeks (nearly 3.5 years). The key finding: continued use of tirzepatide prevented regain, and patients who stayed on the drug saw durable results. This is the strongest evidence yet that ongoing treatment, even at a maintenance level, can sustain the benefits.

The message from the data is consistent: for most people, GLP-1 medications are managing a chronic condition rather than providing a one-time fix. Stopping without replacing what the drug was doing biologically almost always leads to regain.

Why People Stop GLP-1 Medications

Understanding why people discontinue helps frame the right conversation about maintenance. Based on patient surveys, prescriber reports, and what I see in online communities, these are the most common reasons.

Cost. This is the number one reason. Brand-name Wegovy and Zepbound cost $900-$1,349 per month at list price. Even with telehealth compounded options at $149-$299 per month, the cumulative cost adds up fast. After a year on medication at $200 per month, you have spent $2,400. Many people hit a point where they feel they cannot justify the ongoing expense, especially if they have reached their goal weight.

Side effects. Nausea, constipation, and fatigue are the most common GLP-1 side effects, and for some patients they never fully resolve. About 5-10% of trial participants discontinued due to adverse events. If the side effects make daily life miserable, stopping becomes a quality-of-life decision. Our side effects guide covers what to expect and how to manage them.

Reaching goal weight. Some patients hit their target and assume the job is done. This is the most dangerous reason to stop, because it ignores the biological reality of what happens next. Reaching a goal weight is a milestone, not a finish line.

Pregnancy planning. GLP-1 medications are not approved for use during pregnancy. Women planning to conceive need to stop at least two months before trying (the exact washout period depends on the drug). This is a medically necessary stop, and it requires a specific maintenance plan for the gap.

Insurance changes. Job changes, plan changes, or prior authorization denials can cut off coverage overnight. When your insurance suddenly stops paying for a $1,000-per-month medication, the decision gets made for you.

Supply issues. Though improving in 2026, intermittent shortages of specific doses have forced some patients into involuntary breaks. These unplanned stops are particularly risky because there is no time to build a tapering protocol.

What Happens to Your Body When You Stop

The timeline of changes after stopping a GLP-1 follows a predictable pattern. Knowing what to expect removes the surprise factor and helps you plan.

Week 1-2: Appetite begins to return. The half-life of semaglutide is about 7 days. Tirzepatide’s half-life is about 5 days. Within one to two weeks of your last injection, the drug levels in your blood drop below therapeutic levels. Most people notice hunger returning within this window. The “food noise” that went quiet while on medication starts getting louder.

Week 2-4: Full appetite restoration. By the end of the first month, the appetite suppression from the medication is effectively gone. Ghrelin (the hunger hormone) increases. Leptin (the satiety hormone) remains low because your fat stores are reduced. This creates a biological mismatch: your body is signaling that it needs more food, because it perceives the lower body weight as a deficit state.

Month 1-3: Metabolic adaptation becomes noticeable. Your resting metabolic rate, which already slowed during weight loss, does not bounce back just because you stopped the drug. A person who weighs 175 lbs after losing 30 lbs burns fewer calories at rest than someone who has always weighed 175 lbs. This gap can be 200-300 calories per day, and it persists for years in many cases. Combined with increased appetite, this creates a strong drive toward weight regain.

Month 3-6: Weight regain accelerates. In the clinical trials, the steepest regain curve happened in the first six months off the drug. This is when the combination of restored appetite, metabolic adaptation, and (for many people) a return to old eating patterns hits hardest.

Month 6-12: Regain typically plateaus. By 12 months, most of the regain that is going to happen has happened. The STEP 1 extension data showed regain stabilizing around the two-thirds mark. Not everyone regains the full two-thirds. Some regain more. Some regain less. But the average stabilization point is roughly 60-70% of original weight loss regained.

Maintenance Dosing vs. Full Stop

This is the question that comes up more than any other in the GLP-1 community: do I need to stay on this forever, or can I stop?

The honest answer based on the data is that many people will need some form of ongoing medication to maintain their results. That does not necessarily mean staying on your full therapeutic dose. It means finding a maintenance level that keeps the biological forces in check without the cost and side effects of a full dose.

Full therapeutic dose maintenance. This is what SURMOUNT-5 tested. Patients who stayed on their full tirzepatide dose maintained their weight loss over 3+ years. The results were durable. The downside: full-dose maintenance costs the same as active treatment, and side effects continue at the same intensity.

Reduced-dose maintenance. This is the approach gaining traction among prescribers and patients. The idea: once you reach your goal weight, you step down to a lower dose (for example, from Mounjaro 10mg to 2.5mg or 5mg). The lower dose provides enough GLP-1 receptor activation to blunt appetite and support metabolic function, without the full appetite suppression and side effects of a higher dose.

There is limited large-scale trial data on reduced-dose maintenance specifically. But the biological logic is sound. You do not need the same drug intensity to maintain a weight as you needed to lose it. And anecdotally, many patients and prescribers report success with this approach.

Micro-dosing. Some patients are taking even lower doses than the standard minimum. This might mean using 1.25mg of tirzepatide (splitting a 2.5mg dose) or using compounded versions at custom low doses. The evidence base here is thin, but the principle is the same: some GLP-1 support is better than none for patients who are prone to regain.

Full stop. For some patients, stopping entirely is the right choice. If you have built strong habits (protein intake, resistance training, sleep), maintained your goal weight for 6+ months on a stable dose, and have a clear stop-loss plan for catching any regain early, a full stop is reasonable to attempt. Just go in with eyes open about the statistics.

The “Runway” Concept: Building Habits While Still on Medication

I think of GLP-1 medication as a runway. The drug gives you a window where appetite is suppressed, cravings are manageable, and making good choices feels much easier than it did before. That window is your runway. The question is whether you use it just to lose weight, or whether you also use it to build the habits and metabolic infrastructure that will keep the weight off after you stop.

Most people focus only on the weight loss part. They ride the appetite suppression, watch the scale go down, and figure they will deal with maintenance later. That is like using a runway to accelerate but never building wings.

What to build during your medication runway:

1. Protein habits. Getting 0.8-1.0 grams of protein per pound of body weight every day needs to be automatic, not something you think about. This takes months to wire in. Start now while the medication makes it easier to be deliberate about food choices. Our muscle preservation protocol has specific targets and food sources.

2. Resistance training routine. Three sessions per week of compound lifts, done consistently for months, becomes part of your identity rather than something you have to force. The goal is to make training feel wrong to skip, not something you need motivation to do.

3. Food awareness without the drug. Pay attention to how your hunger patterns change around injection day. Notice what true hunger feels like versus habitual eating versus emotional eating. The medication gives you enough distance from your appetite to observe these patterns clearly. That awareness persists after you stop.

4. Sleep discipline. Seven to nine hours of consistent sleep is one of the strongest predictors of successful weight maintenance. Build the routine now: consistent bedtime, dark room, no screens before bed. These habits need to be locked in before you lose the medication buffer.

5. Monitoring systems. Daily weigh-ins with a 7-day rolling average. Quarterly DEXA scans or body measurements. A clear stop-loss weight that triggers restarting medication. Set these up now so they are routine when you eventually taper or stop.

The runway concept also applies to maintenance dosing. If you plan to step down to a lower dose, that lower dose is still a runway, just a shorter one. Use the remaining appetite support to fine-tune the habits you will need at zero medication.

Exercise and Diet Protocols for Maintenance

The patients who maintain weight loss after stopping GLP-1s are almost always the ones who exercise regularly and eat deliberately. The National Weight Control Registry, which tracks over 10,000 people who maintained 30+ lb weight loss for a year or more, found that 90% exercise about an hour per day and most follow a high-protein, calorie-conscious diet.

Resistance training. This is the most important form of exercise for maintenance. It preserves lean mass, which protects your resting metabolic rate. Three sessions per week of compound lifts (squat, bench press, deadlift, rows, overhead press) is the minimum effective dose. Our muscle preservation protocol has the full training split I follow.

Protein targets. Aim for 0.8-1.0 grams per pound of body weight daily. At 180 lbs, that is 144-180 grams per day. Protein is the most satiating macronutrient. When the GLP-1 appetite suppression is gone, high protein intake partially fills that gap by keeping you fuller longer. It also has the highest thermic effect of any macronutrient, meaning your body burns 20-30% of protein calories just during digestion.

Calorie awareness. You do not need to count calories forever. But you do need a general sense of your maintenance calorie range and the ability to recognize when you are consistently exceeding it. Periodic tracking (one week per month, for example) can serve as a calibration tool without the burden of daily logging.

Walking. Daily movement beyond structured exercise matters. Aim for 8,000-10,000 steps per day. This non-exercise activity thermogenesis (NEAT) accounts for a meaningful portion of your daily calorie burn and tends to drop after weight loss unless you actively maintain it.

The Cost of Maintenance Dosing vs. Restarting

One argument against maintenance dosing is cost: why pay for medication every month if you have already lost the weight? The financial comparison is worth examining.

The math often favors maintenance dosing over the stop-and-restart cycle. Restarting after regain means paying full price again for 3-6 months of active weight loss, plus the physical and emotional cost of re-losing weight you already lost once. A low-dose maintenance prescription at $100-$150 per month is often cheaper over a two-year period than one restart cycle.

For a full breakdown of GLP-1 pricing by provider, see our cheapest GLP-1 online guide and provider directory.

When Is It Safe to Stop?

Not everyone is ready to stop at the same time. Here is a framework for evaluating whether you are in a good position to attempt discontinuation.

Criteria for considering a full stop:

1. Weight stable for 3+ months. Your weight should be flat (within 2-3 lbs) on a 7-day rolling average for at least three months before you start tapering. If you are still actively losing, it is too early.

2. Habits are automatic, not effortful. Protein intake, resistance training, sleep, and monitoring should feel like part of your routine. If you still have to force yourself to hit protein targets or drag yourself to the gym, the habits are not locked in yet.

3. Body composition targets met. The scale number matters less than your body fat percentage and lean mass. If your DEXA shows you are at a healthy body composition (under 25% body fat for men, under 32% for women, as general ranges), you are in a better position than someone who hit a scale target but has not addressed body composition.

4. Emotional relationship with food addressed. If you were using food for stress relief, comfort, or emotional regulation before starting the medication, stopping the drug will not fix that. Many patients benefit from working with a therapist or counselor on these patterns while still on medication.

5. Support system in place. A prescriber who will monitor you post-medication, a clear stop-loss weight, and a plan for how to restart quickly if needed. Going it alone without medical oversight increases your risk.

6. No major life stressors on the horizon. Starting a new job, moving, going through a breakup, or any major stress event is not the time to stop appetite-suppressing medication. Your cortisol will already be working against you. Pick a stable period.

My Personal Approach: The Taper Plan

I have not started tapering yet. I am still working toward my goal of 165 lbs at 13-15% body fat. But I have already mapped out my plan based on the data and my own risk tolerance.

Phase 1: Reach and hold goal weight. I need to hit 165 lbs and hold it for three full months on my current dose (7.5mg tirzepatide). No rushing this. The hold period is where I prove the habits are solid.

Phase 2: First step-down. Drop from 7.5mg to 5mg. Hold for 8 weeks. Monitor weight daily with a 7-day rolling average. If the trend stays flat (within 3 lbs), continue. If I see consistent upward drift, hold at 5mg longer before dropping further.

Phase 3: Second step-down. Drop from 5mg to 2.5mg. Hold for 12 weeks. This is the critical window. Going from a low dose to the lowest dose is where many people first notice appetite returning. The longer hold period gives my body time to adjust.

Phase 4: Assess and decide. After 12 weeks on 2.5mg, I will reassess. If my weight is stable, habits are strong, and I feel in control of appetite, I may try stopping entirely. If appetite is creeping back or weight is drifting up, I stay on 2.5mg as a long-term maintenance dose. No ego about it.

The total taper timeline is roughly 6-7 months from the first dose reduction to a potential full stop. That feels long, but given the regain data, I would rather spend an extra few months tapering than rush it and end up back where I started.

For the specific tactical protocol covering the four pillars of maintenance (protein, training, sleep, stress management), read our GLP-1 exit strategy guide. That guide covers the daily playbook. This guide covers the strategic framework.

Provider Options for Maintenance Dosing

Not all providers support maintenance dosing. Some telehealth platforms are set up for active weight loss treatment and will not prescribe lower doses once you hit your goal. Here is what to look for.

What to ask your provider:

• Do you support maintenance dosing at lower levels after goal weight is reached?
• Can I get 2.5mg tirzepatide (or equivalent low-dose semaglutide) as a long-term prescription?
• What is your monitoring protocol for patients in maintenance?
• If I stop entirely and need to restart, how quickly can I get back on medication?

Providers known for flexible dosing: Several telehealth platforms, including MEDVi and others in our provider directory, offer maintenance-dose prescriptions. Compounding pharmacies can also create custom low doses that brand-name pen formats do not offer (for example, 1.25mg tirzepatide by splitting a standard vial).

LillyDirect and NovoCare: Both manufacturer direct programs sell the lowest dose levels. LillyDirect offers Zepbound 2.5mg vials at $299 per month. NovoCare offers Wegovy starter doses. These are options for patients who want brand-name medication at a maintenance level.

FAQ

How much weight do you regain after stopping Ozempic or Mounjaro?

The STEP 1 extension trial found that patients regained approximately two-thirds of weight lost within one year of stopping semaglutide. SURMOUNT-4 data for tirzepatide showed about 50% regain in one year. Individual results vary, but significant regain is the norm rather than the exception when stopping without a maintenance plan.

Can you stay on a low dose of Mounjaro forever?

There is no established safety concern with long-term low-dose tirzepatide use based on current data. SURMOUNT-5 showed durable results over 3+ years of continued use. Many prescribers are comfortable with long-term maintenance dosing. The main barriers are cost and the patient’s preference for not being on medication indefinitely.

What is the cheapest way to do GLP-1 maintenance dosing?

Compounded low-dose semaglutide through a telehealth provider is typically the cheapest option, starting around $79-$129 per month. Compounded low-dose tirzepatide runs $99-$149 per month at many providers. Brand-name options start at $199 per month (NovoCare Wegovy) or $299 per month (LillyDirect Zepbound). See our cheapest GLP-1 guide for current pricing.

How long does it take for appetite to come back after stopping a GLP-1?

Most patients notice appetite returning within one to two weeks of their last injection. Full appetite restoration typically happens within three to four weeks. The timeline varies by individual metabolism, dose, and how long you were on the medication. Patients who were on higher doses for longer tend to notice a more dramatic return of appetite.

Is GLP-1 weight loss permanent if you build good habits?

Some patients do maintain their weight loss after stopping, particularly those who have built strong exercise and nutrition habits during treatment. But the clinical data shows that most patients regain a significant portion of lost weight. Building habits improves your odds but does not guarantee permanence, because the biological forces driving regain (metabolic adaptation, hormonal changes) persist regardless of habits. A combined approach of habits plus a maintenance plan (potentially including low-dose medication) gives the best results.

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. ClearMetabolic may earn a commission through provider links on this page. See our full disclosure.

Related

Guides:

• GLP-1 Exit Strategy · Muscle Preservation Protocol · Exercise and Muscle
• Cheapest GLP-1 Online · Insurance Coverage · Side Effects
• Fat Loss vs Weight Loss · DEXA Scan Results · Mounjaro Dosage Guide

Provider Reviews: Ro · Hims · MEDVi · Found · Calibrate

Tools: GLP-1 Cost Estimator · Body Composition Calculator

Compare: All Providers · Best GLP-1 Programs · All Guides